{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:12:03Z","timestamp":1788228723358,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lymph node metastasis is the most important prognostic factor in patients with lung squamous cell carcinoma. The current findings show that lymph node metastatic tumor cells can arise by programming metastasis in primary tumor cells. Thereby, the genetic alterations responsible for the metastasis could be detected in the primary tumors. This bioinformatic study aimed to determine novel potential prognostic biomarkers shared between primary lung squamous cell tumors (without lymph node metastasis) and lymphatic metastasis, using the Cancer Genome Atlas database. Differentially expressed genes were screened by limma statistical package in R environment. Gene ontology and biological pathways analyses were performed using Enrichr for up-regulated and down-regulated genes. Also, we selected lymph node metastasis related genes among DEGs using correlation analysis between DEGs and suitable references genes for metastasis. Receiver operating characteristic curves was applied using pROC and R package ggplot2 to evaluate diagnostic value of differentially expressed genes. In addition, survival and drug resistance analyses were performed for differentially expressed genes. The miRNA-mRNA interaction networks were predicted by miRwalk and TargetScan databases and expression levels analysis of the miRNAs which were mainly targeting mRNAs was performed using UALCAN database. Protein\u2013protein interaction network analysis and hub genes identification were performed using FunRich and Cytoscape plugin cytoHubba. In this study, a total of 397 genes were differentially expressed not only with a significant difference between N\u2009+\u2009vs. normal and N0 vs. normal but also with significant difference between N\u2009+\u2009vs. N0. Identified GO terms and biological pathways were consistent with DEGs role in the lung squamous cell carcinoma and lymph node metastasis. A significant correlation between 56 genes out of 397 differentially expressed genes with reference genes prompted them being considered for identifying lymph node metastasis of lung squamous cell carcinoma. In addition, <jats:italic>SLC46A2<\/jats:italic>, <jats:italic>ZNF367<\/jats:italic>, <jats:italic>AC107214.1<\/jats:italic> and <jats:italic>NCBP1<\/jats:italic> genes were identified as survival-related genes of patients with lung squamous cell carcinoma. Moreover, <jats:italic>NEDD9<\/jats:italic>, <jats:italic>MRPL21<\/jats:italic>, <jats:italic>SNRPF<\/jats:italic>, and <jats:italic>SCLT1<\/jats:italic> genes were identified to be involved in lung squamous cell carcinoma drug sensitivity\/resistance. We have identified several numbers of miRNAs and their related target genes which could emerge as potential diagnostic biomarkers. Finally, <jats:italic>CDK1<\/jats:italic>, <jats:italic>PLK1<\/jats:italic>, <jats:italic>PCNA<\/jats:italic>, <jats:italic>ZWINT<\/jats:italic> and <jats:italic>NDC80<\/jats:italic> identified as hub genes for underlying molecular mechanisms of lung squamous cell carcinoma and lymphatic metastasis. Our study highlights new target genes according to their relation to lymph node metastasis, whose expressions in the primary lung squamous cell carcinoma are able to accurately assess the presence of lymphatic metastasis.<\/jats:p>","DOI":"10.1038\/s41598-023-33897-3","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T09:03:09Z","timestamp":1682413389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Genes whose expressions in the primary lung squamous cell carcinoma are able to accurately predict the progression of metastasis through lymphatic system, inferred from a bioinformatics analyses"],"prefix":"10.1038","volume":"13","author":[{"given":"Khalil","family":"Khashei Varnamkhasti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Moghanibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirous","family":"Naeimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"4","key":"33897_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.21037\/tlcr-22-252","volume":"11","author":"W Jiang","year":"2022","unstructured":"Jiang, W. et al. The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoadjuvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study. Transl Lung Cancer Res. 11(4), 647\u2013655. https:\/\/doi.org\/10.21037\/tlcr-22-252 (2022).","journal-title":"Transl Lung Cancer Res."},{"key":"33897_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/path.6015","author":"J Lu","year":"2022","unstructured":"Lu, J. et al. Identification of tumour-infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma. J Pathol. https:\/\/doi.org\/10.1002\/path.6015 (2022).","journal-title":"J Pathol."},{"key":"33897_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/2394-4722.157974","volume":"1","author":"A Savini","year":"2015","unstructured":"Savini, A. et al. Squamous cell carcinoma of the lung: clinical criteria for treatment strategy. J. Cancer Metastasis Treat. 1, 90\u201393. https:\/\/doi.org\/10.4103\/2394-4722.157974 (2015).","journal-title":"J. Cancer Metastasis Treat."},{"issue":"6","key":"33897_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3892\/etm.2022.11360","volume":"23","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Yang, J., Sun, X. J., Lu, S. N. & Liu, S. Positive therapy outcome of lung squamous cell cancer: A case report. Exp. Ther. Med. 23(6), 433. https:\/\/doi.org\/10.3892\/etm.2022.11360 (2022).","journal-title":"Exp. Ther. Med."},{"issue":"12","key":"33897_CR5","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.jtho.2016.08.138","volume":"11","author":"CJ Langer","year":"2016","unstructured":"Langer, C. J. et al. Incremental innovation and progress in advanced squamous cell lung cancer: Current status and future impact of treatment. J. Thorac. Oncol. 11(12), 2066\u20132081. https:\/\/doi.org\/10.1016\/j.jtho.2016.08.138 (2016).","journal-title":"J. Thorac. Oncol."},{"key":"33897_CR6","doi-asserted-by":"publisher","first-page":"e10089","DOI":"10.7717\/peerj.10089","volume":"8","author":"S Dong","year":"2020","unstructured":"Dong, S., Zhu, P. & Zhang, S. Expression of collagen type 1 alpha 1 indicates lymph node metastasis and poor outcomes in squamous cell carcinomas of the lung. PeerJ 8, e10089. https:\/\/doi.org\/10.7717\/peerj.10089 (2020).","journal-title":"PeerJ"},{"issue":"6","key":"33897_CR7","first-page":"493","volume":"55","author":"M Rydzanicz","year":"2008","unstructured":"Rydzanicz, M. et al. Nonrandom DNA copy number changes related to lymph node metastases in squamous cell carcinoma of the lung. Neoplasma 55(6), 493\u2013500 (2008).","journal-title":"Neoplasma"},{"key":"33897_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mvr.2014.07.004","volume":"95","author":"S Podgrabinska","year":"2014","unstructured":"Podgrabinska, S. & Skobe, M. Role of lymphatic vasculature in regional and distant metastases. Microvasc. Res. 95, 46\u201352. https:\/\/doi.org\/10.1016\/j.mvr.2014.07.004 (2014).","journal-title":"Microvasc. Res."},{"issue":"1","key":"33897_CR9","doi-asserted-by":"publisher","first-page":"e20190218","DOI":"10.1084\/jem.20190218","volume":"218","author":"AA Abdul Pari","year":"2021","unstructured":"Abdul Pari, A. A., Singhal, M. & Augustin, H. G. Emerging paradigms in metastasis research. J. Exp. Med. 218(1), e20190218. https:\/\/doi.org\/10.1084\/jem.20190218 (2021).","journal-title":"J. Exp. Med."},{"issue":"3","key":"33897_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/cells10030627","volume":"10","author":"H Zhou","year":"2021","unstructured":"Zhou, H., Lei, P. J. & Padera, T. P. Progression of metastasis through lymphatic system. Cells 10(3), 627. https:\/\/doi.org\/10.3390\/cells10030627 (2021).","journal-title":"Cells"},{"issue":"5","key":"33897_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13402-016-0281-9","volume":"39","author":"R Paduch","year":"2016","unstructured":"Paduch, R. The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol. (Dordr.) 39(5), 397\u2013410. https:\/\/doi.org\/10.1007\/s13402-016-0281-9 (2016).","journal-title":"Cell Oncol. (Dordr.)"},{"issue":"2","key":"33897_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.trecan.2021.11.002","volume":"8","author":"P Gui","year":"2022","unstructured":"Gui, P. & Bivona, T. G. Evolution of metastasis: New tools and insights. Trends Cancer 8(2), 98\u2013109 (2022).","journal-title":"Trends Cancer"},{"key":"33897_CR13","doi-asserted-by":"publisher","first-page":"15886","DOI":"10.1038\/srep15886","volume":"5","author":"KN Yamamoto","year":"2015","unstructured":"Yamamoto, K. N., Nakamura, A. & Haeno, H. The evolution of tumor metastasis during clonal expansion with alterations in metastasis driver genes. Sci. Rep. 5, 15886. https:\/\/doi.org\/10.1038\/srep15886 (2015).","journal-title":"Sci. Rep."},{"issue":"6900","key":"33897_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/418823a","volume":"418","author":"R Bernards","year":"2002","unstructured":"Bernards, R. & Weinberg, R. A. A progression puzzle. Nature 418(6900), 823. https:\/\/doi.org\/10.1038\/418823a (2002).","journal-title":"Nature"},{"issue":"4","key":"33897_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta, G. P. & Massagu\u00e9, J. Cancer metastasis: Building a framework. Cell 127(4), 679\u2013695. https:\/\/doi.org\/10.1016\/j.cell.2006.11.001 (2006).","journal-title":"Cell"},{"issue":"6024","key":"33897_CR16","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331(6024), 1559\u20131564. https:\/\/doi.org\/10.1126\/science.1203543 (2011).","journal-title":"Science"},{"key":"33897_CR17","doi-asserted-by":"publisher","first-page":"940405","DOI":"10.1155\/2012\/940405","volume":"2012","author":"JL Johnson","year":"2012","unstructured":"Johnson, J. L., Pillai, S. & Chellappan, S. P. Genetic and biochemical alterations in non-small cell lung cancer. Biochem. Res. Int. 2012, 940405. https:\/\/doi.org\/10.1155\/2012\/940405 (2012).","journal-title":"Biochem. Res. Int."},{"issue":"3","key":"33897_CR18","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.21037\/jtd.2018.01.176","volume":"10","author":"J Zhao","year":"2018","unstructured":"Zhao, J., Li, J., Li, N. & Gao, S. Clinical significance of skipping mediastinal lymph node metastasis in N2 non-small cell lung cancer. J. Thorac. Dis. 10(3), 1683\u20131688. https:\/\/doi.org\/10.21037\/jtd.2018.01.176 (2018).","journal-title":"J. Thorac. Dis."},{"issue":"2","key":"33897_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.thorsurg.2011.11.001","volume":"22","author":"F Fazi","year":"2012","unstructured":"Fazi, F. & Fontemaggi, G. MicroRNAs and lymph node metastatic disease in lung cancer. Thorac. Surg. Clin. 22(2), 167\u2013175. https:\/\/doi.org\/10.1016\/j.thorsurg.2011.11.001 (2012).","journal-title":"Thorac. Surg. Clin."},{"issue":"3","key":"33897_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41391-022-00537-2","volume":"25","author":"AP Alarc\u00f3n-Zendejas","year":"2022","unstructured":"Alarc\u00f3n-Zendejas, A. P. et al. The promising role of new molecular biomarkers in prostate cancer: From coding and non-coding genes to artificial intelligence approaches. Prostate Cancer Prostatic Dis. 25(3), 431\u2013443. https:\/\/doi.org\/10.1038\/s41391-022-00537-2 (2022).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"2A","key":"33897_CR21","first-page":"733","volume":"22","author":"N Euer","year":"2002","unstructured":"Euer, N. et al. Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. Anticancer Res. 22(2A), 733\u2013740 (2002).","journal-title":"Anticancer Res."},{"issue":"3B","key":"33897_CR22","first-page":"1771","volume":"21","author":"M Schwirzke","year":"2001","unstructured":"Schwirzke, M. et al. Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines. Anticancer Res. 21(3B), 1771\u20136 (2001).","journal-title":"Anticancer Res."},{"key":"33897_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar, D. S. et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia 25, 18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001 (2022).","journal-title":"Neoplasia"},{"issue":"11","key":"33897_CR24","doi-asserted-by":"publisher","first-page":"166747","DOI":"10.1016\/j.jmb.2020.166747","volume":"433","author":"P Fonseka","year":"2021","unstructured":"Fonseka, P., Pathan, M., Chitti, S. V., Kang, T. & Mathivanan, S. FunRich enables enrichment analysis of OMICs datasets. J. Mol. Biol. 433(11), 166747. https:\/\/doi.org\/10.1016\/j.jmb.2020.166747 (2021).","journal-title":"J. Mol. Biol."},{"issue":"4","key":"33897_CR25","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin, C. H. et al. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8(4), S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11 (2014).","journal-title":"BMC Syst. Biol."},{"issue":"1","key":"33897_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jss.2004.06.002","volume":"122","author":"M Takada","year":"2004","unstructured":"Takada, M. et al. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer. J. Surg. Res. 122(1), 61\u201369. https:\/\/doi.org\/10.1016\/j.jss.2004.06.002 (2004).","journal-title":"J. Surg. Res."},{"issue":"9","key":"33897_CR27","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1158\/1078-0432.CCR-19-2184","volume":"26","author":"K Pocha","year":"2020","unstructured":"Pocha, K. et al. Surfactant expression defines an inflamed subtype of lung adenocarcinoma brain metastases that correlates with prolonged survival. Clin. Cancer Res. 26(9), 2231\u20132243. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2184 (2020).","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"33897_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000326299","volume":"81","author":"M K\u00f6nigshoff","year":"2011","unstructured":"K\u00f6nigshoff, M. Lung cancer in pulmonary fibrosis: Tales of epithelial cell plasticity. Respiration 81(5), 353\u2013358. https:\/\/doi.org\/10.1159\/000326299 (2011).","journal-title":"Respiration"},{"issue":"9","key":"33897_CR29","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1111\/febs.15531","volume":"288","author":"MD Pizzagalli","year":"2021","unstructured":"Pizzagalli, M. D., Bensimon, A. & Superti-Furga, G. A guide to plasma membrane solute carrier proteins. FEBS J. 288(9), 2784\u20132835. https:\/\/doi.org\/10.1111\/febs.15531 (2021).","journal-title":"FEBS J."},{"key":"33897_CR30","doi-asserted-by":"publisher","first-page":"786069","DOI":"10.3389\/fimmu.2021.786069","volume":"12","author":"A Alcaraz-Sanabria","year":"2022","unstructured":"Alcaraz-Sanabria, A. et al. Transcriptomic mapping of non-small cell lung cancer K-RAS p.G12C mutated tumors: Identification of surfaceome targets and immunologic correlates. Front. Immunol. 12, 786069. https:\/\/doi.org\/10.3389\/fimmu.2021.786069 (2022).","journal-title":"Front. Immunol."},{"issue":"12","key":"33897_CR31","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1038\/s41388-020-1166-y","volume":"39","author":"X Wu","year":"2020","unstructured":"Wu, X. et al. Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer. Oncogene 39(12), 2568\u20132582. https:\/\/doi.org\/10.1038\/s41388-020-1166-y (2020).","journal-title":"Oncogene"},{"issue":"12","key":"33897_CR32","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.7150\/ijbs.44204","volume":"16","author":"H Zeng","year":"2020","unstructured":"Zeng, H. et al. ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer. Int. J. Biol. Sci. 16(12), 2084\u20132093. https:\/\/doi.org\/10.7150\/ijbs.44204 (2020).","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"33897_CR33","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.1111\/jcmm.14581","volume":"23","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B. J. Cell Mol. Med. 23(10), 6965\u20136977. https:\/\/doi.org\/10.1111\/jcmm.14581 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"33897_CR34","doi-asserted-by":"publisher","first-page":"876360","DOI":"10.3389\/fonc.2022.876360","volume":"12","author":"F Lu","year":"2022","unstructured":"Lu, F. et al. Construction of a novel prognostic model in lung adenocarcinoma based on 7-methylguanosine-related gene signatures. Front. Oncol. 12, 876360. https:\/\/doi.org\/10.3389\/fonc.2022.876360 (2022).","journal-title":"Front. Oncol."},{"issue":"5\u20136","key":"33897_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/1947601912458585","volume":"3","author":"MS Guerrero","year":"2012","unstructured":"Guerrero, M. S., Parsons, J. T. & Bouton, A. H. Cas and NEDD9 contribute to tumor progression through dynamic regulation of the cytoskeleton. Genes Cancer 3(5\u20136), 371\u2013381. https:\/\/doi.org\/10.1177\/1947601912458585 (2012).","journal-title":"Genes Cancer"},{"issue":"22","key":"33897_CR36","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1158\/1078-0432.CCR-11-2162","volume":"18","author":"S Kondo","year":"2012","unstructured":"Kondo, S. et al. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer. Clin. Cancer Res. 18(22), 6326\u20136338. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2162 (2012).","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"33897_CR37","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/cancers12061466","volume":"12","author":"E Aaseb\u00f8","year":"2020","unstructured":"Aaseb\u00f8, E. et al. The progression of acute myeloid leukemia from first diagnosis to chemoresistant relapse: A comparison of proteomic and phosphoproteomic profiles. Cancers (Basel) 12(6), 1466. https:\/\/doi.org\/10.3390\/cancers12061466 (2020).","journal-title":"Cancers (Basel)"},{"issue":"22","key":"33897_CR38","doi-asserted-by":"publisher","first-page":"8879","DOI":"10.3390\/ijms21228879","volume":"21","author":"G Huang","year":"2020","unstructured":"Huang, G., Li, H. & Zhang, H. Abnormal expression of mitochondrial ribosomal proteins and their encoding genes with cell apoptosis and diseases. Int. J. Mol. Sci. 21(22), 8879. https:\/\/doi.org\/10.3390\/ijms21228879 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"33897_CR39","first-page":"114","volume":"8","author":"Y Liu","year":"2021","unstructured":"Liu, Y. & Gong, Y. SCLT1 depletion impair hepatoma cell survival by suppressing cell proliferation and promoting apoptosis. Int. J. Sci. 8(4), 114\u2013120 (2021).","journal-title":"Int. J. Sci."},{"issue":"6","key":"33897_CR40","first-page":"4207","volume":"14","author":"FP Li","year":"2022","unstructured":"Li, F. P. et al. Overexpressed SNRPB\/D1\/D3\/E\/F\/G correlate with poor survival and immune infiltration in hepatocellular carcinoma. Am. J. Transl. Res. 14(6), 4207\u20134228 (2022).","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"33897_CR41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3892\/mmr.2017.6100","volume":"15","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. A novel pathway in NSCLC cells: miR-191, targeting NFIA, is induced by chronic hypoxia, and promotes cell proliferation and migration. Mol. Med. Rep. 15(3), 1319\u20131325. https:\/\/doi.org\/10.3892\/mmr.2017.6100 (2017).","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"33897_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/15384047.2018.1507257","volume":"20","author":"M Lin","year":"2019","unstructured":"Lin, M., Yao, Z., Zhao, N. & Zhang, C. TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway. Cancer Biol. Ther. 20(1), 101\u2013108. https:\/\/doi.org\/10.1080\/15384047.2018.1507257 (2019).","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"33897_CR43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bbrc.2019.03.082","volume":"512","author":"H Li","year":"2019","unstructured":"Li, H. et al. MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A. Biochem. Biophys. Res. Commun. 512(2), 392\u2013398. https:\/\/doi.org\/10.1016\/j.bbrc.2019.03.082 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"33897_CR44","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1039\/c7mb00400a","volume":"13","author":"H Motieghader","year":"2017","unstructured":"Motieghader, H., Kouhsar, M., Najafi, A., Sadeghi, B. & Masoudi-Nejad, A. mRNA-miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation. Mol. Biosyst. 13(10), 2168\u20132180. https:\/\/doi.org\/10.1039\/c7mb00400a (2017).","journal-title":"Mol. Biosyst."},{"issue":"7","key":"33897_CR45","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/cancers13071493","volume":"13","author":"CMS Silva","year":"2021","unstructured":"Silva, C. M. S. et al. Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a promising microRNA signature for the detection of colorectal cancer. Cancers (Basel) 13(7), 1493. https:\/\/doi.org\/10.3390\/cancers13071493 (2021).","journal-title":"Cancers (Basel)"},{"issue":"7\u20138","key":"33897_CR46","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1002\/jcp.29488","volume":"235","author":"E Gharib","year":"2020","unstructured":"Gharib, E., Nasri Nasrabadi, P. & Reza, Z. M. miR-497-5p mediates starvation-induced death in colon cancer cells by targeting acyl-CoA synthetase-5 and modulation of lipid metabolism. J. Cell Physiol. 235(7\u20138), 5570\u20135589. https:\/\/doi.org\/10.1002\/jcp.29488 (2020).","journal-title":"J. Cell Physiol."},{"issue":"6","key":"33897_CR47","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3892\/or.2020.7573","volume":"43","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Oncol. Rep. 43(6), 1831\u20131844. https:\/\/doi.org\/10.3892\/or.2020.7573 (2020).","journal-title":"Oncol. Rep."},{"issue":"9","key":"33897_CR48","doi-asserted-by":"publisher","first-page":"e24647","DOI":"10.1002\/jcla.24647","volume":"36","author":"C Wang","year":"2022","unstructured":"Wang, C., Xie, X., Li, W. & Jiang, D. Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis. J. Clin. Lab. Anal. 36(9), e24647. https:\/\/doi.org\/10.1002\/jcla.24647 (2022).","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"33897_CR49","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12920-020-00812-y","volume":"13","author":"L Zeng","year":"2020","unstructured":"Zeng, L. et al. Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma. BMC Med. Genom. 13(1), 158. https:\/\/doi.org\/10.1186\/s12920-020-00812-y (2020).","journal-title":"BMC Med. Genom."},{"issue":"2","key":"33897_CR50","doi-asserted-by":"publisher","first-page":"300060519897508","DOI":"10.1177\/0300060519897508","volume":"48","author":"M Li","year":"2020","unstructured":"Li, M., He, F., Zhang, Z., Xiang, Z. & Hu, D. CDK1 serves as a potential prognostic biomarker and target for lung cancer. J. Int. Med. Res. 48(2), 300060519897508. https:\/\/doi.org\/10.1177\/0300060519897508 (2020).","journal-title":"J. Int. Med. Res."},{"key":"33897_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.21037\/dmr-20-98","volume":"3","author":"C Chai","year":"2020","unstructured":"Chai, C., Yang, Z., Huang, M., Xu, J. & Lu, X. CDK1\/TTR\/MYC promote the formation of metastatic niches and affect the prognosis of pancreatic cancer by participating in immune CD4+ T cell infiltration as indicated by an integrated bioinformatics analysis. Dig. Med. Res. 3, 40. https:\/\/doi.org\/10.21037\/dmr-20-98 (2020).","journal-title":"Dig. Med. Res."},{"issue":"13","key":"33897_CR52","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.3390\/ijms23137385","volume":"23","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. CDK1 promotes epithelial-mesenchymal transition and migration of head and neck squamous carcinoma cells by repressing \u2206Np63\u03b1-mediated transcriptional regulation. Int. J. Mol. Sci. 23(13), 7385. https:\/\/doi.org\/10.3390\/ijms23137385 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"33897_CR53","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3892\/mmr.2015.4597","volume":"13","author":"W Zhou","year":"2016","unstructured":"Zhou, W., Zhu, Y., Chen, S., Xu, R. & Wang, K. Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcoma. Mol. Med. Rep. 13(1), 713\u2013719. https:\/\/doi.org\/10.3892\/mmr.2015.4597 (2016).","journal-title":"Mol. Med. Rep."},{"issue":"Pt 15","key":"33897_CR54","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1242\/jcs.00653","volume":"116","author":"G Maga","year":"2003","unstructured":"Maga, G. & Hubscher, U. Proliferating cell nuclear antigen (PCNA): A dancer with many partners. J. Cell Sci. 116(Pt 15), 3051\u20133060. https:\/\/doi.org\/10.1242\/jcs.00653 (2003).","journal-title":"J. Cell Sci."},{"issue":"7","key":"33897_CR55","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/aob\/mcq243","volume":"107","author":"W Strzalka","year":"2011","unstructured":"Strzalka, W. & Ziemienowicz, A. Proliferating cell nuclear antigen (PCNA): A key factor in DNA replication and cell cycle regulation. Ann. Bot. 107(7), 1127\u20131140. https:\/\/doi.org\/10.1093\/aob\/mcq243 (2011).","journal-title":"Ann. Bot."},{"issue":"2","key":"33897_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/(SICI)1096-9098(199602)61:2<106::AID-JSO4>3.0.CO;2-G","volume":"61","author":"H Isozaki","year":"1996","unstructured":"Isozaki, H. et al. Significance of proliferating cell nuclear antigen (PCNA) expression in gastric cancer in relation to lymph node metastasis. J. Surg. Oncol. 61(2), 106\u2013110. https:\/\/doi.org\/10.1002\/(SICI)1096-9098(199602)61:2%3c106::AID-JSO4%3e3.0.CO;2-G (1996).","journal-title":"J. Surg. Oncol."},{"key":"33897_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.biopha.2018.05.071","volume":"104","author":"L Wang","year":"2018","unstructured":"Wang, L., Kong, W., Liu, B. & Zhang, X. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer. Biomed. Pharmacother. 104, 595\u2013602. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.071 (2018).","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"33897_CR58","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4161\/cc.5.8.2692","volume":"5","author":"BC van de Weerdt","year":"2006","unstructured":"van de Weerdt, B. C. & Medema, R. H. Polo-like kinases: A team in control of the division. Cell Cycle 5(8), 853\u2013864. https:\/\/doi.org\/10.4161\/cc.5.8.2692 (2006).","journal-title":"Cell Cycle"},{"issue":"2","key":"33897_CR59","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1158\/1078-0432.CCR-09-1380","volume":"16","author":"Y Degenhardt","year":"2010","unstructured":"Degenhardt, Y. & Lampkin, T. Targeting Polo-like kinase in cancer therapy. Clin. Cancer Res. 16(2), 384\u2013389. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1380 (2010).","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"33897_CR60","doi-asserted-by":"publisher","first-page":"11106","DOI":"10.1158\/0008-5472.CAN-07-2348","volume":"67","author":"A Rizki","year":"2007","unstructured":"Rizki, A., Mott, J. D. & Bissell, M. J. Polo-like kinase 1 is involved in invasion through extracellular matrix. Cancer Res. 67(23), 11106\u201311110. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2348 (2007).","journal-title":"Cancer Res."},{"issue":"6","key":"33897_CR61","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3892\/etm.2012.729","volume":"4","author":"XG Zhang","year":"2012","unstructured":"Zhang, X. G., Lu, X. F., Jiao, X. M., Chen, B. & Wu, J. X. PLK1 gene suppresses cell invasion of undifferentiated thyroid carcinoma through the inhibition of CD44v6, MMP-2 and MMP-9. Exp. Ther. Med. 4(6), 1005\u20131009. https:\/\/doi.org\/10.3892\/etm.2012.729 (2012).","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"33897_CR62","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41388-019-1023-z","volume":"39","author":"SB Shin","year":"2020","unstructured":"Shin, S. B., Jang, H. R., Xu, R., Won, J. Y. & Yim, H. Active PLK1-driven metastasis is amplified by TGF-\u03b2 signaling that forms a positive feedback loop in non-small cell lung cancer. Oncogene 39(4), 767\u2013785. https:\/\/doi.org\/10.1038\/s41388-019-1023-z (2020).","journal-title":"Oncogene"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33897-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33897-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33897-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T10:10:01Z","timestamp":1682417401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33897-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33897"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33897-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6733"}}